Seed

Los Angeles, United States Founded: 2016 • Age: 10 yrs
Synbiotics are developed for simulating the gut microbiome.

About Seed

Seed is a Healthcare company based in Los Angeles (United States) founded in 2016 by Raja Dhir and Ara Katz. Synbiotics are developed for simulating the gut microbiome. Seed has raised $40.62 million across 3 funding rounds from investors including TCG Ventures, The Craftory and Artis Ventures. Seed has completed 1 acquisition, including auggi. Its chief executive, as recorded, is Raja Dhir. Its website seed.com draws about 1.4 million monthly visits. Its focus areas include Life Sciences, Genomics, Applied Genomics and Consumer Genomics. Its competitors include Ironwood Pharma, Evelo Biosciences and Alcresta; 3 of its 3 listed competitors have raised funding.

Company details

Seed was founded in 2016 in Los Angeles, United States, within the biotechnology sector focused on gut health. Synbiotics are developed using metabolomic sequencing and a proprietary platform for screening host mechanistic pathways. Probiotics containing strains with GRAS or QPS status have been created, with evidence of improvements in gastrointestinal, cardiovascular, and dermatological health markers. Operations center on microbiome simulation and strain validation.

  • Headquarters Los Angeles, United States
  • Founders Raja Dhir, Ara Katz
  • Sectors
    Healthcare
  • Website category Lifestyle · Beauty and Cosmetics
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website seed.com
  • Social LinkedIn X Facebook
Key Metrics
  • Total Equity Funding
    $40.62M (USD)

    in 3 rounds

  • Latest Funding Round
    $40.62M (USD), Series A

    Apr 2021

  • Investors
  • Investments & Acquisitions

Funding Insights of Seed

Seed has successfully raised a total of $40.62M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $40.62 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $40.62M
  • Total Rounds 3
  • Last Round Series A — $40.62M
  • Investors Count 12

All 3 funding rounds of Seed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2021$40.62MSeries A–The Craftory
Jan 2019Series A––
Jun 2018Series A–Bold Capital Partners, 8VC
–
Valuation history

12 investors in total: 12 institutional.

Investors in Seed

Seed has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include TCG Ventures, The Craftory and Artis Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
A global investor focused on consumer packaged goods brands.
thecraftory.ioLondon, United Kingdom
Early-stage startups are invested in by Artis Ventures.
av.coSan Francisco, United States
Venture capital investments in technology and defense sectors.
foundersfund.com
Venture capital firm investing in technology, life sciences, and related sectors.
8vc.com
Early-stage life sciences and tech focused VC firm investing primarily in the US
boldcapitalpartners.comSanta Monica, United States
Multiple sectors are targeted for venture capital investments by Greycroft.
greycroft.comNew York, United States
Investing in early-stage tech companies and ideas.
boxgroup.com
A seed-stage venture capital firm
macventurecapital.comLos Angeles, United States
Private equity firm investing in multiple sectors
collabfund.comNew York, United States
magichour.vc
Premium access

Investor details for Seed

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Seed

25 people are tracked at Seed (5 in leadership, 16 in board & advisors, 4 in team).

NameRoleGroup
Raja Dhir
Co-Founder & Co-CEOLeadership
Ara Katz
Co-Founder & Co-CEOLeadership
George Church
Co-Director of SeedLabsLeadership
Tess Marshall
Senior Director, Product MarketingLeadership
Karthik M.
Director, U.s RetailLeadership
Martin J. Blaser
Scientific AdvisorBoard & advisors
Geoffrey Preidis
Scientific AdvisorBoard & advisors
Gregor Reid
Scientific Board MemberBoard & advisors
Jacques Ravel
Co-ChairBoard & advisors
Maria Gloria Dominguez Bello
Scientific AdvisorBoard & advisors
Joseph Petrosino
Scientific AdvisorBoard & advisors
Kari Nadeau
Scientific AdvisorBoard & advisors
Shruti Naik
Scientific AdvisorBoard & advisors
Janet Jansson
Scientific AdvisorBoard & advisors
Maurizio Fava
Scientific AdvisorBoard & advisors
John Ryals
Scientific AdvisorBoard & advisors
Alessio Fasano
Scientific AdvisorBoard & advisors
James Versalovic
Scientific AdvisorBoard & advisors
Sarkis Mazmanian
Scientific AdvisorBoard & advisors
Christopher Mason
Scientific AdvisorBoard & advisors

5 more people are available in the full profile.

Premium access

Complete people profiles for Seed

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Seed

Seed has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include auggi.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Gut health is monitored via an AI-driven online platform.
auggi.aiNew York, United States2018Feb 2021••••
Premium access

Complete acquisition details for Seed

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Seed

4 dated milestones of Seed across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Seed is founded.
  2. Funding First funding round.
  3. Acquisition Acquires auggi.
  4. Funding Latest funding round, Series A, of $40.6M.

Competitors of Seed

Seed has 3 listed competitors in our database, 3 of them funded. They include Ironwood Pharma, Evelo Biosciences and Alcresta.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
ironwoodpharma.com1998Cambridge, United States$206.25M220
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
evelobio.com2015Cambridge, United States$166.5M117
Therapeutics for inflammatory diseases, COVID-19, and cancer are developed.
alcresta.com2011Newton, United States$95.89M52
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
Premium access

Detailed competitors of Seed

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Seed

The website of Seed (seed.com) receives about 1.4M visits a month and ranks #48,711 among all websites worldwide, #2,392 in Beauty and Cosmetics.

  • Monthly visits
    1.4M

    ▲ 33.8% vs previous month

  • Unique visitors
    528.3K

    per month

  • Global rank
    #48,711

    among all websites

  • Category rank
    #2,392

    Lifestyle · Beauty and Cosmetics

Similar websites

Websites whose visitors overlap most with Seed. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
armra.com
armra.com
100%
#82,887–
humnutrition.com
99%
513.8K#147,041View details
trueseamoss.com
trueseamoss.com
98%
–
gruns.co
98%
1.3M#58,471View details
thisisneeded.com
97%
319.6K#138,973View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Seed

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Seed (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Seed

Premium access

Complete news archive for Seed

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seed

Seed was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Seed is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.

Raja Dhir is the CEO of Seed, as recorded in our data. They have also founded this company.

Seed is a funded company, having raised a total of $40.62M across 3 funding rounds to date.

Seed was founded in 2016 in Los Angeles, United States, within the biotechnology sector focused on gut health. Synbiotics are developed using metabolomic sequencing and a proprietary platform for screening host mechanistic pathways. Probiotics containing strains with GRAS or QPS status have been created, with evidence of improvements in gastrointestinal, cardiovascular, and dermatological health markers. Operations center on microbiome simulation and strain validation.

Seed's top competitors include Ironwood Pharma, Alcresta and Evelo Biosciences.

Seed has made 1 acquisition, including auggi.

Seed has 12 investors. Key investors include TCG Ventures, The Craftory, Artis Ventures, Gisev Family Office, and Founders Fund.

The website of Seed receives about 1.4 million visits a month and ranks #48,711 among all websites worldwide.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available